Table 1 Baseline characteristics of the intervention group (INT) and the control group (CONT) presented as mean (SD) or n (%) .
INT (n = 33) | CONT (n = 31) | |
|---|---|---|
Age, years | 59 (6) | 57 (8) |
Sex, n (%) females (n) | 20 (60) | 17 (53) |
Body weight, kg | 92.4 (16.6) | 94.4 (15.8) |
BMI, kg/m2 | 31.0 (4.0) | 31.8 (4.6) |
Waist circumference, cm | 111.1 (11.6) | 110.8 (11.1) |
Body fat, % | 43.1 (8.0) | 43.1 (8.0) |
FFM, kg | 52.6 (11.9) | 53.5 (9.8) |
Cholesterol medication, n (%) | 9 (27) | 5 (16) |
Fasting plasma lipids | ||
HDL mmol/l | 1.3 (0.3) | 1.4 (0.4) |
LDL, mmol/l | 3.1 (0.9) | 3.0 (0.7) |
Total cholesterol, mmol/l | 4.8 (1.0) | 4.6 (0.7) |
HDL% | 28 (6.8) | 31 (8.7) |
TG, mmol/l | 1.6 (0.7) | 1.1 (0.5) |
FFA, mmol/l | 0.6 (0.2) | 0.59 (0.2) |
Activity outcomes | ||
SB, h/day | 10.0 (0.9) | 10.1 (1.1) |
LPA, h/day | 1.7 (0.4) | 1.8 (0.5) |
MVPA, h/day | 0.96 (0.31) | 0.97 (0.3) |
Standing, h/day | 1.8 (0.6) | 1.8 (0.6) |
Steps/day | 5204 (1910) | 5091 (1760) |
Dietary intake | ||
Energy intake, kJ/day | 7271 (1603) | 7789 (1725) |
Energy intake/body mass, kJ/kg/day | 79.7 (16.1) | 84.8 (22.1) |
Protein, g/day | 77.4 (20.7) | 79.5 (20.0) |
CHO, g/day | 165.0 (46.6) | 180.9 (50.6) |
MUFA, g/day | 26.5 (9.0) | 28.4 (9.6) |
PUFA, g/day | 12.1 (5.0) | 13.0 (5.1) |
SFA, g/day | 26.7 (8.8) | 30.4 (8.7) |
Cholesterol, mg/day | 223.1 (104.4) | 287.2 (158.7) |
Fiber, g/day | 18.5 (6.6) | 20.1 (7.6) |
